Pediatric Intensive Care Treatment of Uncontrolled Status Epilepticus

Critical Care Clinics

Volumn 29, Issue 2, 2013, Pages 239-257

  Wilkes, Ryan ^a   Tasker, Robert C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Anesthesia; FIRES epilepsy; Pediatric; Status epilepticus; Super refractory

Indexed keywords

ANTICONVULSIVE AGENT; DESFLURANE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; ISOFLURANE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ACUTE ENCEPHALITIS WITH REFRACTORY REPETITIVE PARTIAL SEIZURE; ACUTE ENCEPHALOPATHY WITH INFLAMMATION MEDIATED STATUS EPILEPTICUS; ANTICONVULSANT THERAPY; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BRAIN BIOPSY; BRAIN METABOLISM; BRAIN SURGERY; CEREBROSPINAL FLUID ANALYSIS; COMPLEX PARTIAL SEIZURE; CONTINUOUS INFUSION; DEVASTATING EPILEPSY IN SCHOOL AGE CHILDREN; DISEASE DURATION; DRUG HALF LIFE; ELECTROENCEPHALOGRAM; EMERGENCY CARE; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; FEVER INDUCED REFRACTORY EPILEPTIC ENCEPHALOPATHY; GENERAL ANESTHESIA; GENERALIZED EPILEPSY; HEART ARRHYTHMIA; HEART RATE; HUMAN; HYPERAMMONEMIA; HYPOTENSION; ILEUS; INTENSIVE CARE; KETOGENIC DIET; LIVER TOXICITY; LUMBAR PUNCTURE; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TACHYPHYLAXIS;

ADJUVANTS, ANESTHESIA; ANTICONVULSANTS; BARBITURATES; CHILD; HUMANS; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; INTUBATION, INTRATRACHEAL; MIDAZOLAM; RESPIRATION, ARTIFICIAL; STATUS EPILEPTICUS;

EID: 84875612739     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.11.007     Document Type: Review

References (75)

1. Tasker R.C. Emergency treatment of acute seizures and status epilepticus. Arch Dis Child 1998, 79:78-83.
2. Meldrum B.S., Horton R.W. Physiology of status epilepticus in primates. Arch Neurol 1973, 28:1-9.
3. Meldrum B.S., Brierley J.B. Prolonged epileptic seizures in primates. Arch Neurol 1973, 28:10-17.
4. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29:82-87.
5. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology 1990, 40(Suppl 2):13-23.
6. Freeman J.M. Status epilepticus: it's not what we've thought or taught. Pediatrics 1989, 83:444-445.
7. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 1993, 34:592-596.
8. Lowenstein D.H., Bleck T., Macdonald R.L. It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
9. Shinnar S., Berg A.T., Moshe S.L., et al. How long do new-onset seizures in children last?. Ann Neurol 2001, 49:659-664.
10. Kramer R., Levisohn P. The duration of secondarily generalized tonic-clonic seizures. Epilepsia 1992, 33:68. [abstract].
11. Theodore W., Porter R., Albert P., et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 1994, 44:1403-1407.
12. Lahat E., Goldman M., Barr J., et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study. BMJ 2000, 321:83-86.
13. Smith R.A., Martland T., Lowry M.F. Children with seizures presenting to accident and emergency. J Accid Emerg Med 1996, 13:54-58.
14. Wasterlain C.G., Chen J.W. Definition and classification of status epilepticus. Status epilepticus: mechanisms and management 2006, 11-16. MIT Press, Cambridge (MA). C.G. Wasterlain, D.M. Treiman (Eds.).
15. Jenssen S., Gracely E.J., Sperling M.R. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006, 47:1499-1503.
16. Mayer S.A., Claassen J., Lokin J., et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
17. Walton N.Y., Treiman D.M. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol 1988, 101:267-275.
18. Treiman D.M., Walton N.Y., Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990, 5:49-60.
19. Wang N.C., Good L.B., Marsh S.T., et al. EEG stages predict treatment response in experimental status epilepticus. Epilepsia 2009, 50:949-952.
20. Sahin M., Menache C.C., Holmes G.L., et al. Outcome of severe refractory status epilepticus in children. Epilepsia 2001, 42:1461-1467.
21. Koul R., Chacko A., Javed H., et al. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome. J Child Neurol 2002, 17:908-910.
22. Lambrechtsen F.A., Buchhalter J.R. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia 2008, 49:615-625.
23. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia 2011, 52(Suppl 8):53-56.
24. Wilder-Smith E.P., Lim E.C., Teoh H.L., et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore 2005, 34:417-420.
25. Van Baalen A., Stephani U., Kluger G., et al. FIRES: febrile infection responsive epileptic (FIRE) encephalopathies of school age. Brain Dev 2009, 31:92-93.
26. Chauvel P., Dravet C. The HHE syndrome. Epileptic syndromes in infancy, childhood and adolescence 2005, 277-293. J Libbey, London. 4th edition. J. Roger, M. Bureau, C. Dravet (Eds.).
27. Nabbout R., Vezzani A., Dulac O., et al. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011, 10:99-108.
28. Ismail F.Y., Kossoff E.H. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities?. Epilepsia 2011, 52:e185-e189.
29. Brevoord J.C., Joosten K.F., Arts W.F., et al. Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol 2005, 20:476-481.
30. Sreenath T.G., Gupta P., Sharma K.K., et al. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. Eur J Paediatr Neurol 2010, 14:162-168.
31. Walton N.Y., Treiman D.M. Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Res 1989, 4:216-221.
32. Abend N.S., Marsh E. Convulsive and nonconvulsive status epilepticus in children. Curr Treat Options Neurol 2009, 11:262-272.
33. Crawford T.O., Mitchell W.G., Fishman L.S., et al. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988, 38:1035-1040.
34. Rogawski M.A., Losher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
35. A receptor complex. Prog Drug Res 1990, 34:261-286.
36. Abend N.S., Dlugos D.J. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatr Neurol 2008, 38:377-390.
37. Tasker R.C. Midazolam for refractory status epilepticus: higher dosing and more rapid and effective control. Intensive Care Med 2006, 32:1935-1936.
38. Morrison G., Gibbons E., Whitehouse W.P. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006, 32:2070-2076.
39. Rossetti A.O. Which anesthetic should be used in the treatment of refractory status epilepticus?. Epilepsia 2007, 48(Suppl 8):52-55.
40. Owens J. Medical management of refractory status epilepticus. Semin Pediatr Neurol 2010, 17:176-181.
41. Stullken E.H., Milde J.H., Michenfelder J.D., et al. The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental. Anesthesiology 1977, 46:28-34.
42. Barberio M., Reiter P.D., Kaufman J., et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol 2012, 27:721-726.
43. Krishnamurthy K.B., Drislane F.W. Depth of EEG suppression and outcome in barbiturate anesthetic for refractory status epilepticus. Epilepsia 1999, 40:759-762.
44. Schreiber J.M., Gaillard W.D. Treatment of refractory status epilepticus in childhood. Curr Neurol Neurosci Rep 2011, 11:195-204.
45. Schmutzhard E., Pfausler B. Complications of the management of status epilepticus in the intensive care unit. Epilepsia 2011, 52(Suppl 8):39-41.
46. Holmes G.L., Riviello J.J. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999, 20:259-264.
47. Claassen J., Hirsch L.J., Emerson R.G., et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146-153.
48. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698-1702.
49. Kim S.J., Lee D.Y., Kim J.S. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 2001, 25:217-220.
50. Kofke W.A., Snider M.T., Young R.S., et al. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology 1989, 71:653-659.
51. Mirsattari S.M., Sharpe M.D., Young G.B. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004, 61:1254-1259.
52. Fugate J.E., Burns J.D., Wijdicks E.F.M., et al. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe?. Anesth Analg 2010, 111:1520-1524.
53. Arnold J.H., Truog R.D., Rice S.A. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg 1993, 76:520-526.
54. Kelsall A.W., Ross-Russell R., Herrick M.J. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med 1994, 22:1032-1034.
55. McBeth C., Watkins T.G. Isoflurane for sedation in a case of congenital myasthenia gravis. Br J Anaesth 1996, 77:672-674.
56. Hughes J., Leach H.J., Choonara I. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatr 1993, 82:885-886.
57. Shankar V., Churchwell K.B., Deshpande J.K. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 2006, 32:927-933.
58. Cellucci T., Benseler S.M. Diagnosing central nervous system vasculitis in children. Curr Opin Pediatr 2010, 22:731-738.
59. Elbers J., Halliday W., Hawkins C., et al. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol 2010, 68:602-610.
60. Moritani T., Smoker W.R., Leee H.K., et al. Differential diagnosis of cerebral hemispheric pathology. Clin Neuroradiol 2011, 21:53-63.
61. Chassoux F., Landre E., Mellerio C., et al. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia 2012, 53:349-358.
62. Aronica E., Becker A.J., Spreafico R. Malformations of cortical development. Brain Pathol 2012, 22:380-401.
63. Loscher W., Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005, 6:591-602.
64. Kuteykin-Teplyakov K., Brandt C., Hoffmann K., et al. Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia 2009, 50:887-897.
65. Bankstahl J.P., Bankstahl M., Kuntner C., et al. A novel emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood brain barrier. J Neurosci 2011, 31:8803-8811.
66. Iannetti P., Spalice A., Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005, 46:967-969.
67. Schmitt F.C., Dehnicke C., Merschhemke M., et al. Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav 2010, 17:565-568.
68. Mirski M., Williams M., Hanley D.F. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995, 23:400-404.
69. Greiner H.M., Tillema J.-M., Hallinan B.E., et al. Corpus callosotomy for treatment of pediatric refractory status epilepticus. Seizure 2012, 21:307-309.
70. Wheless J.W. Treatment of refractory convulsive status epilepticus in children: other therapies. Semin Pediatr Neurol 2010, 17:190-194.
71. Kramer U., Chi C.S., Lin K.L., et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011, 52:1956-1965.
72. Kramer U., Chi C.S., Lin K.L., et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome?. Epilepsia 2011, 52(Suppl 8):28-30.
73. Howell K.B., Katanyuwong K., Mackay M.T., et al. Long-term follow-up febrile infection-related epilepsy syndrome. Epilepsia 2012, 53:101-110.
74. Sakuma H., Awaya Y., Shiomi M., et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand 2010, 121:251-256.
75. Nabbout R., Mazzuca M., Hubert P., et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.